Abstract
Mother-to-child transmission (MTCT) of HIV is the predominant mode of HIV transmission in children worldwide. It is estimated that around 1.3 million children are living with HIV and that approximately 1,600 children are infected with HIV each day. Numerous clinical trials using antiretroviral drugs to reduce MTCT of HIV-1 have shown that perinatal transmission can be reduced effectively. Based on the PACTG 076 study administering a long antenatal zidovudine regimen, a signific ant reduction in vertical HIV-1 transmission has been achieved in the developed world. Trials conducted in developing countries have shown that perinatal transmission can be reduced effectively even using shorter and less costly antiretroviral regimens. Prevention of MTCT interventions have been implemented on a large scale in a number of developing countries.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
